Crick
HomeTrialsGenesDrugs23andMeGraphBlogContact
  • Home
  • Trials
  • Genes
  • Drugs
  • 23andMe
  • Graph
  • Blog
  • Contact
Crick

An open-source clinical intelligence platform. Explore clinical trials, gene networks, and molecular structures using public data sources.

Data Sources

  • ClinicalTrials.gov
  • OpenTargets
  • ClinVar
  • PubChem

Links

  • Contact
  • Privacy

© 2026 Crick. All rights reserved.

Crick is for educational purposes only. Not medical advice.

Results for “NASH - Nonalcoholic Steatohepatitis With Liver Fibrosis”

Filters

Phase
Early Phase 1
Phase 1
Phase 2
Phase 3
Phase 4
Status
Recruiting
Active, Not Recruiting
Not Yet Recruiting
Completed
Enrolling by Invitation

Showing 20 of 0 results

Large-scale testing (Phase 3)Temporarily pausedNCT04104321
What this trial is testing

A Clinical Study to Evaluate the Efficacy and Safety of Aramchol in Subjects With NASH (ARMOR)

Who this might be right for
Nonalcoholic Steatohepatitis (NASH)
Galmed Research and Development, Ltd. 157
Testing effectiveness (Phase 2)Study completedNCT03486912
What this trial is testing

Experimental Medication BMS-986036 in Adults With Nonalcoholic Steatohepatitis (NASH) and Liver Cirrhosis

Who this might be right for
Hepatic CirrhosisLiver FibrosisNonalcoholic Fatty Liver Disease (NAFLD)+1 more
Bristol-Myers Squibb 155
Testing effectiveness (Phase 2)UnknownNCT04255069
What this trial is testing

Evaluate the Efficacy and Safety of JKB-122 in Patients With NASH and Fibrosis

Who this might be right for
Nonalcoholic Steatohepatitis (NASH) With Fibrosis
TaiwanJ Pharmaceuticals Co., Ltd 300
Not applicableStudy completedNCT04785937
What this trial is testing

Accuracy of Imaging Techniques in Diagnosing Steatohepatitis and Fibrosis in NAFLD Patients

Who this might be right for
Non-Alcoholic Fatty Liver DiseaseSteatohepatitis, NonalcoholicLiver Fibroses
Azienda USL Reggio Emilia - IRCCS 28
Testing effectiveness (Phase 2)Ended earlyNCT03059446
What this trial is testing

Rollover Study of Cenicriviroc for the Treatment of Liver Fibrosis in Participants With Nonalcoholic Steatohepatitis

Who this might be right for
Nonalcoholic SteatohepatitisLiver CirrhosisNon-alcoholic Fatty Liver Disease
Tobira Therapeutics, Inc. 167
Testing effectiveness (Phase 2)Ended earlyNCT01672866
What this trial is testing

Safety and Efficacy of Simtuzumab (SIM, GS-6624) in Adults With Advanced Liver Fibrosis But Not Cirrhosis Secondary to Non-Alcoholic Steatohepatitis (NASH)

Who this might be right for
Liver Fibrosis Due to NASH
Gilead Sciences 222
Large-scale testing (Phase 3)Ended earlyNCT02548351
What this trial is testing

Randomized Global Phase 3 Study to Evaluate the Impact on NASH With Fibrosis of Obeticholic Acid Treatment

Who this might be right for
Non Alcoholic Steatohepatitis (NASH)
Intercept Pharmaceuticals 2,477
Testing effectiveness (Phase 2)Study completedNCT05327127
What this trial is testing

Study to Evaluate the Efficacy and Safety of K-877-ER and CSG452 in Participants With NASH With Liver Fibrosis

Who this might be right for
NASH
Kowa Research Institute, Inc. 228
Large-scale testing (Phase 3)Study completedNCT02030977
What this trial is testing

The Effects of Resveratrol Supplement on Biochemical Factors and Hepatic Fibrosis in Patients With Nonalcoholic Steatohepatitis

Who this might be right for
Non Alcoholic Fatty Liver
Dr Azita Hekmatdoost 50
Testing effectiveness (Phase 2)Study completedNCT03517540
What this trial is testing

Study of Safety, Tolerability, and Efficacy of a Combination Treatment of LJN452 and CVC in Adult Patients With NASH and Liver Fibrosis

Who this might be right for
Non-alcoholic Steatohepatitis (NASH)
Novartis Pharmaceuticals 193
Not applicableNot Yet RecruitingNCT06537466
What this trial is testing

Ketogenic Diet in MASLD-related cACLD

Who this might be right for
Steatohepatitis, NonalcoholicSteatosis of LiverCirrhosis, Liver
University of Palermo 50
Testing effectiveness (Phase 2)Study completedNCT04321031
What this trial is testing

Metabolic Interventions to Resolve Non-alcoholic Steatohepatitis (NASH) With Fibrosis (MIRNA)

Who this might be right for
Nonalcoholic Fatty Liver DiseaseNonalcoholic Steatohepatitis With Liver Fibrosis
Pfizer 256
Not applicableUnknownNCT04369521
What this trial is testing

Evaluation of the Effects of a Low Free Sugar Diet in Patients With Nonalcoholic Fatty Liver Disease

Who this might be right for
Nonalcoholic Fatty Liver Disease
National Nutrition and Food Technology Institute 50
Not applicableActive Not RecruitingNCT04595474
What this trial is testing

Prevalence of NAFLD and Advanced Fibrosis in Patients With Type 1 Diabetes

Who this might be right for
Nonalcoholic Fatty LiverNonalcoholic SteatohepatitisFibrosis, Liver+2 more
Joslin Diabetes Center 533
Not applicableStudy completedNCT04774302
What this trial is testing

Correlation Between Hepatic Fibrosis and Cardiovascular Risk Evaluated by Non-invasive Tests in Patients With NAFLD

Who this might be right for
NAFLD
Clinique Pasteur 292
Testing effectiveness (Phase 2)Study completedNCT03486899
What this trial is testing

Experimental Medication BMS-986036 in Adults With Nonalcoholic Steatohepatitis (NASH) and Stage 3 Liver Fibrosis

Who this might be right for
Liver FibrosisNonalcoholic Fatty Liver Disease (NAFLD)Nonalcoholic Steatohepatitis
Bristol-Myers Squibb 197
Not applicableUnknownNCT03525769
What this trial is testing

Screening With FibroTouch for Advanced Liver Fibrosis in NAFLD Patients With Underlying Type 2 Diabetes

Who this might be right for
Type 2 Diabetes MellitusNonalcoholic Fatty Liver Disease (NAFLD)
Nanfang Hospital, Southern Medical University 10,000
Not applicableLooking for participantsNCT05766449
What this trial is testing

Risk Factors for Hepatic Inflammation, Fibrosis and Prognosis in Patients With CHB and NAFLD

Who this might be right for
Chronic Hepatitis bNon-alcoholic Fatty Liver Disease
The Affiliated Nanjing Drum Tower Hospital of Nanjing University Medical School 1,000
Testing effectiveness (Phase 2)Study completedNCT00013598
What this trial is testing

Treatment of Nonalcoholic Steatohepatitis With Pioglitazone

Who this might be right for
Fatty LiverNonalcoholic Steatohepatitis
National Institute of Diabetes and Digestive and Kidney Diseases (NIDDK) 30
Testing effectiveness (Phase 2)Study completedNCT05011305
What this trial is testing

Saroglitazar Magnesium for the Treatment of Nonalcoholic Steatohepatitis With Fibrosis

Who this might be right for
Nonalcoholic SteatohepatitisFibrosis
Zydus Therapeutics Inc. 189
Next Page